KLF17 and hepatocellular carcinoma: Additionally, Liu et al. reported that KLF17 inhibited hepatocellular carcinoma (HCC) cell motility and invasion possibly via counteracting EMT, and reduced expression of KLF17 was associated with poor prognosis in HCC [11].